DELIVER Therapeutics

Manufacturing · Texas, United States · 1-10 Employees

View Company Info for Free

Overview

Headquarters

2710 Reed Rd Ste 160, Houston, Texas, 77...

Revenue

<$5 Million

Industry

Manufacturing Pharmaceuticals Business Services Research & Development
ZI Rank: 1
Signal Type
Feb
Mar
Apr
May
Jun
Jul
ZI Rank
1
1
1
1
1
1

About DELIVER Therapeutics

DELiver Therapeutics specializes in developing novel small molecule therapeutics using advanced drug screening technologies to address significant challenges in cancer treatment. Their focus includes creating best-in-class multi-kinase inhibitors that target key tyrosine kinases, particularly for patients with Ph+ Acute Lymphocytic Leukemia. Additionally, they are working on therapies to regulate the senescence-associated secretory phenotype (SASP) to mitigate age-related diseases. The company aims to deliver innovative solutions for both cancer patients and those affected by aging-related conditions.Explore more
DELIVER Therapeutics's Social MediaPopular SearchesDELIVER Therapeutics IncSIC Code 28,283NAICS Code 32,325Show more

DELIVER Therapeutics Org Chart

PhoneEmail
MC
United States flag for contact location.

Director, Preclinical Development

PhoneEmail

PhoneEmail
Get the full picture
Sign in to uncover key details.
NP
United States flag for contact location.

Associate Researcher

PhoneEmail

PhoneEmail
Get the full picture
Sign in to uncover key details.

Is DELIVER Therapeutics your ideal customer?

Let us give you the heads up on whether it's a good time to reach out

Recommended Actions

Compare Similar Companies to DELIVER Therapeutics

Compare insights from companies similar to DELIVER Therapeutics, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.

Company Name

Revenue

Number of Employees

Type

Funding

Founded In

Top Executive

DELIVER Therapeutics

<$5M
1-10
Private
-
2020
MC
Michael CorselloDirector, Preclinical Development
$6M
11-50
Private
-
2015
N/A
<$5M
11-50
Private
-
1996
KD
Krisha DoshiManager, Product Marketing
<$5M
11-50
Private
<$5M
2011
JL
John LawrenceCompany Director
<$5M
11-50
Private
-
2004
<$5M
1-10
Private
-
2017
Yufang Shao, President at Bon Opus Biosciences
Yufang ShaoPresident
<$5M
1-10
Private
-
2005
Illustration of an envelope

Company Profile Activity

i

Among all Manufacturing companies

Low Activity

High Activity

Activity Insights

DELIVER Therapeutics is experiencing very low activity levels compared to other companies in the Manufacturing sector.

What does this means?

DELIVER Therapeutics is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about DELIVER Therapeutics.

DELIVER Therapeutics Tech Stack

A closer look at the technologies used by DELIVER Therapeutics

Top Manufacturing Companies

Frequently Asked Questions Regarding DELIVER Therapeutics

What is DELIVER Therapeutics's official website?
DELIVER Therapeutics's official website is www.delivertherapeutics.com
What is DELIVER Therapeutics's Revenue?
DELIVER Therapeutics's revenue is <$5 Million
What is DELIVER Therapeutics's SIC code?
DELIVER Therapeutics's SIC: 28,283
What is DELIVER Therapeutics's NAICS code?
DELIVER Therapeutics's NAICS: 32,325
How many employees does DELIVER Therapeutics have?
DELIVER Therapeutics has 1-10 employees
What industry does DELIVER Therapeutics belong to?
DELIVER Therapeutics is in the industry of: Manufacturing, Pharmaceuticals, Business Services
What is DELIVER Therapeutics competition?
DELIVER Therapeutics top competitors include: ExonBIO, Biologics International, Bon Opus Biosciences, AbBioSci
What technology does DELIVER Therapeutics use?
Some of the popular technologies that DELIVER Therapeutics uses are: WordPress.org, PHP, Google Font API, Google Tag Manager
What does DELIVER Therapeutics do?

DELiver Therapeutics specializes in developing novel small molecule therapeutics using advanced drug screening technologies to address significant challenges in cancer treatment. Their focus includes creating best-in-class multi-kinase inhibitors that target key tyrosine kinases, particularly for patients with Ph+ Acute Lymphocytic Leukemia. Additi... onally, they are working on therapies to regulate the senescence-associated secretory phenotype (SASP) to mitigate age-related diseases. The company aims to deliver innovative solutions for both cancer patients and those affected by aging-related conditions.Read More

What are DELIVER Therapeutics social media links?
DELIVER Therapeutics Linkedin page
Is DELIVER Therapeutics a public company?
DELIVER Therapeutics is private company therefore does not currently have an official ticker symbol
See more information about DELIVER Therapeutics

Get Started with ZoomInfo

Register for free

Sign Up for Free

Get started for free! No credit card needed. Enjoy up to 25 free contacts each month at no cost.
Elevate your prospecting to the next level

Supercharge Your Prospecting

Search ZoomInfo's database of 106M+ companies and 140M+ professionals to find your next lead.
Expand your business

Grow Your Business

Reveal both personal and business contact details, including emails and phone numbers, and close your most valuable buyers.